title: Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six-week placebo-controlled, double-blind, multicentre trial.
abstract: BACKGROUND
  This study aimed to assess the efficacy of artichoke leaf extract (ALE) in the treatment of patients with functional dyspepsia (FD).
  
  
  METHODS
  In a double-blind, randomized controlled trial (RCT), 247 patients with functional dyspepsia were recruited and treated with either a commercial ALE preparation (2 x 320 mg plant extract t.d.s.) or a placebo. The primary efficacy variable was the sum score of the patient's weekly rating of the overall change in dyspeptic symptoms (four-point scale). Secondary variables were the scores of each dyspeptic symptom and the quality of life (QOL) as assessed by the Nepean Dyspepsia Index (NDI).
  
  
  RESULTS
  Two hundred and forty-seven patients were enrolled, and data from 244 patients (129 active treatment, 115 placebo) were suitable for inclusion in the statistical analysis (intention-to-treat). The overall symptom improvement over the 6 weeks of treatment was significantly greater with ALE than with the placebo (8.3 +/- 4.6, vs. 6.7 +/- 4.8, P < 0.01). Similarly, patients treated with ALE showed significantly greater improvement in the global quality-of-life scores (NDI) compared with the placebo-treated patients (- 41.1 +/- 47.6 vs. - 24.8 +/- 35.6, P < 0.01).
  
  
  CONCLUSIONS
  The ALE preparation tested was significantly better than the placebo in alleviating symptoms and improving the disease-specific quality of life in patients with functional dyspepsia.
authors.affiliation: Division of Internal Medicine, Department of Gastroenterology, University of Essen, Germany. g.holtmann@uni-essen.de
authors.forename: G
authors.initials: G
authors.lastname: Holtmann
authors.forename: B
authors.initials: B
authors.lastname: Adam
authors.forename: S
authors.initials: S
authors.lastname: Haag
authors.forename: W
authors.initials: W
authors.lastname: Collet
authors.forename: E
authors.initials: E
authors.lastname: Grünewald
authors.forename: T
authors.initials: T
authors.lastname: Windeck
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D031943:Cynara scolymus / Q000009:adverse effects; D004311:Double-Blind Method; D004415:Dyspepsia / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008517:Phytotherapy / Q000009:adverse effects / Q000379:methods*; D010936:Plant Extracts / Q000009:adverse effects / Q000627:therapeutic use*; D018515:Plant Leaves; D011788:Quality of Life; D016896:Treatment Outcome
chemical_list: D010936:Plant Extracts